|

paclitaxel plus carboplatin Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Carbo/Taxol®

Pipeline

Phase 3: 1

Top Sponsors

  • Immatics US, Inc.1
  • Fudan University1

Indications

  • Cancer2
  • Melanoma, Cutaneous Malignant1
  • Survival1
  • Chemoradiotherapy1
  • Esophageal Squamous Cell Carcinoma1

Other1 trial

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
N/A

Phoenix, Arizona1 trial

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

Mayo Clinic

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.